Metabolic surgery provides better results, lesser regression than standard diabetes management

Eliem Ther­a­peu­tics has un­der­gone a strate­gic re­view just two years af­ter launch­ing dur­ing the pan­dem­ic biotech boom. Eliem said Thurs­day morn­ing it plans to ex­plore

Bay­er stock­hold­ers will be get­ting a lot less re­ward for hold­ing their shares for the next few years. The Ger­man gi­ant is plan­ning to dras­ti­cal­ly

Patients with highly active systemic lupus erythematosus (SLE) appeared to sustain much less organ damage and fewer disease flares when drug therapy yielded substantial relief,